HEERLEN, THE NETHERLANDS: Royal DSM is in exclusive discussions with Cargill which may, or may not result in the acquisition of Cargill’s cultures and enzymes business by DSM. Both companies are now engaging in the information and consultation process with employee representative bodies in the relevant countries.
The cultures and enzymes business of Cargill is a global leading manufacturer of cultures and enzymes for dairy and meat industries with manufacturing operations in Wisconsin (USA) and France. It has a strong pipeline of new products built on three pillars of technology: culture texture toolbox, fast acidification for cheese yield improvements and culture flavour systems. The business generates net sales of about €45 million per year with approximately 200 employees.
The global market for cultures and enzymes is valued at over €1 billion, growing steadily at more than 5 per cent per annum. A possible combination of the Cargill cultures and enzymes business with the dairy business of DSM Food Specialties would be highly complementary creating a strong global player and enabling DSM to propel sales growth as well as capture sizable synergies in global manufacturing footprint, customer reach as well as innovation capabilities in biotechnology and SG&A.
The acquisition forms an integral part of DSM’s strategy for its Nutrition cluster. “This acquisition would be another great step in achieving our ambitious growth strategy. Combining both businesses would allow us to serve our customers faster with one of the most versatile offerings in cultures and enzymes in the global dairy industry,” said Hans-Christian Ambjerg, President, Food Specialties, DSM.
© WOC News